Free Trial
NASDAQ:BIOX

Bioceres Crop Solutions (BIOX) Stock Price, News & Analysis

Bioceres Crop Solutions logo
$4.47 +0.06 (+1.36%)
As of 03:26 PM Eastern

About Bioceres Crop Solutions Stock (NASDAQ:BIOX)

Key Stats

Today's Range
$4.38
$4.63
50-Day Range
$4.11
$5.16
52-Week Range
$3.51
$11.78
Volume
65,897 shs
Average Volume
182,147 shs
Market Capitalization
$280.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.63
Consensus Rating
Buy

Company Overview

Bioceres Crop Solutions Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

BIOX MarketRank™: 

Bioceres Crop Solutions scored higher than 53% of companies evaluated by MarketBeat, and ranked 93rd out of 142 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bioceres Crop Solutions has received a consensus rating of Buy. The company's average rating score is 3.20, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Bioceres Crop Solutions has only been the subject of 1 research reports in the past 90 days.

  • Read more about Bioceres Crop Solutions' stock forecast and price target.
  • Earnings Growth

    Earnings for Bioceres Crop Solutions are expected to grow in the coming year, from ($0.05) to $0.38 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bioceres Crop Solutions is -32.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bioceres Crop Solutions is -32.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Bioceres Crop Solutions has a PEG Ratio of 1.40. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Bioceres Crop Solutions has a P/B Ratio of 0.81. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Bioceres Crop Solutions' valuation and earnings.
  • Percentage of Shares Shorted

    1.86% of the float of Bioceres Crop Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Bioceres Crop Solutions has a short interest ratio ("days to cover") of 5.
  • Change versus previous month

    Short interest in Bioceres Crop Solutions has recently decreased by 8.68%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Bioceres Crop Solutions does not currently pay a dividend.

  • Dividend Growth

    Bioceres Crop Solutions does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.86% of the float of Bioceres Crop Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Bioceres Crop Solutions has a short interest ratio ("days to cover") of 5.
  • Change versus previous month

    Short interest in Bioceres Crop Solutions has recently decreased by 8.68%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Bioceres Crop Solutions has a news sentiment score of -0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Bioceres Crop Solutions this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for BIOX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
Receive BIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioceres Crop Solutions and its competitors with MarketBeat's FREE daily newsletter.

BIOX Stock News Headlines

BIOX Bioceres Crop Solutions Corp. - Seeking Alpha
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

BIOX Stock Analysis - Frequently Asked Questions

Bioceres Crop Solutions' stock was trading at $6.08 at the beginning of 2025. Since then, BIOX shares have decreased by 25.7% and is now trading at $4.52.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) issued its quarterly earnings data on Wednesday, May, 21st. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.08. The company earned $59.60 million during the quarter, compared to analyst estimates of $61.80 million. Bioceres Crop Solutions had a negative trailing twelve-month return on equity of 2.37% and a negative net margin of 2.14%.
Read the conference call transcript
.

Bioceres Crop Solutions (BIOX) raised $130 million in an initial public offering on Wednesday, February 7th 2018. The company issued 11,800,000 shares at a price of $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey acted as the underwriters for the IPO and Mirabaud Securities was co-manager.

Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioceres Crop Solutions investors own include NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), Meta Platforms (META), Advanced Micro Devices (AMD), Builders FirstSource (BLDR) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
5/21/2025
Today
7/08/2025
Next Earnings (Estimated)
9/08/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
AGRI OPERATIONS
Sub-Industry
Trading
Current Symbol
NASDAQ:BIOX
Fax
N/A
Employees
500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.63
High Stock Price Target
$13.00
Low Stock Price Target
$6.50
Potential Upside/Downside
+95.6%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.4
Net Income
$3.24 million
Pretax Margin
-4.90%

Debt

Sales & Book Value

Annual Sales
$464.80 million
Cash Flow
$0.35 per share
Price / Cash Flow
12.68
Book Value
$5.56 per share
Price / Book
0.79

Miscellaneous

Free Float
N/A
Market Cap
$276.55 million
Optionable
Optionable
Beta
0.41
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:BIOX) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners